Heart drug may unlock safe exercise for cardiomyopathy patients

This study looks at whether adding a structured exercise program is safe and helpful for people with hypertrophic obstructive cardiomyopathy who are already taking the drug mavacamten. About 24 adults with mild symptoms will either do supervised endurance and strength training for 6 weeks or continue their usual care. Researchers will track side effects, fitness levels, heart function, and quality of life to see if exercise can be a safe addition to their treatment.